Effect of Rimonabant, a Cannabinoid-1 Receptor Blocker, on Weight and Cardiometabolic Risk Factors in Overweight or Obese Patients—Correction

JAMA - Journal of the American Medical Association- United States

doi 10.1001/jama.295.11.1252

Full Text

Abstract

Available in

Categories

Medicine

Date

Authors

Unknown

Publisher

American Medical Association (AMA)

Related search

Is Rimonabant a Safe and Effective Therapy for Sustained Weight Loss and Improved Cardiometabolic Risk Factors?

Nature Clinical Practice Cardiovascular Medicine
2006English

P523 Relationship Between TSH Level and Cardiometabolic Risk Factors in Overweight and Obese Turkish Adolescents

2019English

Effectiveness of a Medifast Meal Replacement Program on Weight, Body Composition and Cardiometabolic Risk Factors in Overweight and Obese Adults: A Multicenter Systematic Retrospective Chart Review Study

Nutrition Journal
MedicineNutritionDietetics
2015English

Effect of Weight Loss on Renal Function in Overweight and Obese Patients With Heart Failure

Diabetes and Metabolic Syndrome: Clinical Research and Reviews
Internal MedicineMedicineDiabetesMetabolismEndocrinology
2017English

Author Correction: Effect of Intermittent Compared to Continuous Energy Restriction on Weight Loss and Weight Maintenance After 12 Months in Healthy Overweight or Obese Adults

International Journal of Obesity
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2019English

Effect of Rimonabant on Blood Pressure in Overweight/Obese Patients With/Without Co-Morbidities: Analysis of Pooled RIO Study Results

Journal of Hypertension
Internal MedicineCardiovascular MedicinePhysiologyCardiology
2008English

Effect of Exercise Training on Cardiometabolic Risk Markers Among Sedentary, but Metabolically Healthy Overweight or Obese Post-Menopausal Women With Elevated Blood Pressure

Atherosclerosis
Cardiovascular MedicineCardiology
2009English

Effect of Diet and Exercise, Alone or Combined, on Weight and Body Composition in Overweight-To-Obese Postmenopausal Women

Obesity
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2012English

Peripheral CB1 Cannabinoid Receptor Blockade Improves Cardiometabolic Risk in Mouse Models of Obesity

Journal of Clinical Investigation
Medicine
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy